1. Home
  2. PODD
  3. PODD News

Latest Insulet Corporation (PODD) News on September 18, 2025

PODD

MT Newswires

2 days ago

Piper Sandler Adjusts Insulet Price Target to $360 From $320, Maintains Overweight Rating

Insulet names new CFO; Dexcom CEO on leave
PODD

MedTech Dive

2 days ago

Insulet names new CFO; Dexcom CEO on leave

PODD

MT Newswires

2 days ago

Insulet Appoints Flavia Pease Finance Chief

Insulet Announces CFO Transition
PODD

Business Wire

2 days ago

Insulet Announces CFO Transition

Here's Why Insulet (PODD) is a Strong Momentum Stock
PODD

Zacks

3 days ago

Here's Why Insulet (PODD) is a Strong Momentum Stock

Why Insulet (PODD) is a Top Growth Stock for the Long-Term
PODD

Zacks

6 days ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

PODD

MT Newswires

6 days ago

JPMorgan Adjusts Price Target on Insulet to $415 From $340, Maintains Overweight Rating

3 Reasons Investors Love Insulet (PODD)
PODD

StockStory

6 days ago

3 Reasons Investors Love Insulet (PODD)

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
PODD

StockStory

7 days ago

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

PODD

MT Newswires

9 days ago

Insulet Insider Sold Shares Worth $278,002, According to a Recent SEC Filing

PODD

MT Newswires

10 days ago

Oppenheimer Adjusts Insulet Price Target to $365 From $324, Maintains Outperform Rating

PODD

Argus Research

15 days ago

PODD: Raising target price to $362.00

Insulet (NASDAQ:PODD) shareholders have earned a 11% CAGR over the last five years
PODD

Simply Wall St.

16 days ago

Insulet (NASDAQ:PODD) shareholders have earned a 11% CAGR over the last five years

Omnipod Maker Insulet Is In A Buy Zone As Its Market Expands To Millions
PODD

Investor's Business Daily

20 days ago

Omnipod Maker Insulet Is In A Buy Zone As Its Market Expands To Millions

Here's Why Insulet (PODD) is a Strong Growth Stock
PODD

Zacks

22 days ago

Here's Why Insulet (PODD) is a Strong Growth Stock

Insulet promotes Eric Benjamin to chief operating officer
PODD

MedTech Dive

23 days ago

Insulet promotes Eric Benjamin to chief operating officer

Insulet Gains 77.2% in a Year: What's Driving the Rally?
PODD

Zacks

a month ago

Insulet Gains 77.2% in a Year: What's Driving the Rally?

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating
PODD

Investor's Business Daily

a month ago

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

PODD

MT Newswires

a month ago

Barclays Adjusts Price Target on Insulet to $300 From $266, Maintains Equalweight Rating

Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.
PODD

Investor's Business Daily

a month ago

Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.

Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now
PODD

Investor's Business Daily

a month ago

Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now

Insulet Stock Breaks Out — Again — As Momentum Continues
PODD

Investor's Business Daily

a month ago

Insulet Stock Breaks Out — Again — As Momentum Continues

Insulet to Participate in Upcoming Investor Conferences
PODD

Business Wire

a month ago

Insulet to Participate in Upcoming Investor Conferences

Diabetes stocks rally after RFK comments on HHS campaign
PODD

TipRanks

3 months ago

Diabetes stocks rally after RFK comments on HHS campaign

PODD

Argus Research

3 months ago

PODD: Raising target price to $326.00

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
PODD

Barchart

3 months ago

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions
PODD

Business Wire

3 months ago

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
PODD

TipRanks

3 months ago

Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

PODD

Investing.com

3 months ago

Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth

PODD

MT Newswires

3 months ago

Truist Initiates Insulet at Buy With $365 Price Target

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of
PODD

StockStory

3 months ago

1 Cash-Producing Stock with Exciting Potential and 2 to Steer Clear Of

Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility
PODD

Simply Wall St.

3 months ago

Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility

Here's Why You Should Retain PODD Stock in Your Portfolio Now
PODD

Zacks

3 months ago

Here's Why You Should Retain PODD Stock in Your Portfolio Now

PODD

Argus Research

3 months ago

PODD: Rating decreased to a HOLD

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users
PODD

Business Wire

3 months ago

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption
PODD

StockStory

3 months ago

PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
PODD

Zacks

3 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

3 Reasons Investors Love Insulet (PODD)
PODD

StockStory

3 months ago

3 Reasons Investors Love Insulet (PODD)

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks
PODD

StockStory

3 months ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

Here's Why Insulet (PODD) is a Strong Growth Stock
PODD

Zacks

3 months ago

Here's Why Insulet (PODD) is a Strong Growth Stock

PODD

MT Newswires

3 months ago

TD Cowen Adjusts Price Target on Insulet to $379 From $324

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF
PODD

Zacks

3 months ago

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)
PODD

StockStory

3 months ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

Solventum Stock Earns RS Rating Upgrade
PODD

Investor's Business Daily

4 months ago

Solventum Stock Earns RS Rating Upgrade

1 Surging Stock with Exciting Potential and 2 to Question
PODD

StockStory

4 months ago

1 Surging Stock with Exciting Potential and 2 to Question

PODD

Investing.com

4 months ago

Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy

PODD

MT Newswires

4 months ago

Goldman Sachs Initiates Insulet at Buy With $380 Price Target

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?
PODD

Simply Wall St.

4 months ago

Is Insulet Corporation (NASDAQ:PODD) A High Quality Stock To Own?

PODD

MT Newswires

4 months ago

Raymond James Adjusts Price Target on Insulet to $360 From $328, Maintains Outperform Rating

Insulet Gains 78.5% in a Year: What's Driving the Stock?
PODD

Zacks

4 months ago

Insulet Gains 78.5% in a Year: What's Driving the Stock?

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
PODD

Business Wire

4 months ago

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies
PODD

Zacks

4 months ago

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies

PODD

MT Newswires

4 months ago

Citigroup Adjusts Price Target on Insulet to $380 From $320, Maintains Buy Rating

4 Medical Product Stocks to Watch From a Challenging Industry
PODD

Zacks

4 months ago

4 Medical Product Stocks to Watch From a Challenging Industry

Why Insulet (PODD) is a Top Growth Stock for the Long-Term
PODD

Zacks

4 months ago

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

PODD

MT Newswires

4 months ago

Bernstein Adjusts Insulet Price Target to $375 From $355

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest
PODD

StockStory

4 months ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

PODD

MT Newswires

4 months ago

Insulet Insider Sold Shares Worth $960,320, According to a Recent SEC Filing

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today
PODD

Insider Monkey

4 months ago

Insulet Corporation (PODD): Among the Stocks Analysts Are Upgrading Today

Outlier Money Flows Lift Insulet
PODD

FX Empire

4 months ago

Outlier Money Flows Lift Insulet

1 Mid-Cap Stock to Target This Week and 2 to Avoid
PODD

StockStory

4 months ago

1 Mid-Cap Stock to Target This Week and 2 to Avoid

PODD

Argus Research

4 months ago

PODD: Raising target price to $346.00

PODD

MT Newswires

4 months ago

Morgan Stanley Adjusts Price Target on Insulet to $355 From $325, Maintains Overweight Rating

Insulet Announces Publication of 2024 Sustainability Report
PODD

Business Wire

4 months ago

Insulet Announces Publication of 2024 Sustainability Report

PODD

MT Newswires

4 months ago

Wolfe Research Upgrades Insulet to Outperform From Peer Perform, Price Target is $350

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised
PODD

Zacks

4 months ago

Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View Raised

PODD

MT Newswires

4 months ago

Redburn Atlantic Adjusts Price Target on Insulet to $350 From $315, Maintains Buy Rating

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points
PODD

Investor's Business Daily

4 months ago

S&P 500 Giants Visa, Insulet Lead 5 Stocks Near Buy Points

PODD

Morningstar Research

4 months ago

Analyst Report: Insulet Corporation

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks
PODD

Investopedia

4 months ago

S&P 500 Gains & Losses Today: Index Pulls Back Early Climb Amid Anticipation of Trade Talks

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops
PODD

Investor's Business Daily

4 months ago

Insulet Stock Soars To A High After Robust Earnings; This Customer Management Name Pops

Why Insulet (PODD) Stock Is Trading Up Today
PODD

StockStory

4 months ago

Why Insulet (PODD) Stock Is Trading Up Today

Insulet Stock Soars to Lead S&P 500 Gainers Friday
PODD

Investopedia

4 months ago

Insulet Stock Soars to Lead S&P 500 Gainers Friday

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops
PODD

Yahoo Finance Video

4 months ago

Insulet Q1 beat, Sweetgreen sinks on outlook, Wolfspeed drops

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025
PODD

Simply Wall St.

4 months ago

Insulet (NasdaqGS:PODD) Announces $125M Buyback, Raises Revenue Guidance For 2025

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More
PODD

Investopedia

4 months ago

Top Stock Movers Now: Tesla, Monster Beverage, Insulet, and More

PODD

MT Newswires

4 months ago

RBC Raises Price Target on Insulet to $330 From $325, Keeps Outperform Rating

PODD

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Insulet Corp Earnings Call

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys
PODD

Investor's Business Daily

4 months ago

Dow Jones Futures Rise As Trump Says 80% China Tariff 'Seems Right'; Robinhood Leads 6 New Buys

PODD

MT Newswires

4 months ago

Canaccord Genuity Lifts Price Target on Insulet to $331 From $324, Maintains Buy Rating

PODD

MT Newswires

4 months ago

Oppenheimer Adjusts Price Target on Insulet to $324 From $312, Maintains Outperform Rating

PODD

MT Newswires

4 months ago

Baird Adjusts Price Target on Insulet to $350 From $325, Maintains Outperform Rating

PODD

MT Newswires

4 months ago

Wells Fargo Adjusts Price Target on Insulet to $330 From $322, Maintains Overweight Rating

PODD

MT Newswires

4 months ago

Bernstein Adjusts Price Target on Insulet to $355 From $335, Maintains Outperform Rating

What To Expect From Insulet’s (PODD) Q1 Earnings
PODD

StockStory

4 months ago

What To Expect From Insulet’s (PODD) Q1 Earnings

PODD

Argus Research

4 months ago

PODD: Raising target price to $285.00

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics
PODD

Zacks

4 months ago

Curious about Insulet (PODD) Q1 Performance? Explore Wall Street Estimates for Key Metrics

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About
PODD

StockStory

4 months ago

1 Growth Stock with Impressive Fundamentals and 2 to Think Twice About

PODD

MT Newswires

5 months ago

Insulet Shares Fall After Wolfe Research Downgrade

PODD

MT Newswires

5 months ago

Wolfe Research Downgrades Insulet to Peer Perform From Outperform

Insulet Names New CEO, Expects to Top Revenue Projections
PODD

Investopedia

5 months ago

Insulet Names New CEO, Expects to Top Revenue Projections

Ashley McEvoy named Insulet CEO
PODD

MedTech Dive

5 months ago

Ashley McEvoy named Insulet CEO

1 Healthcare Stock Worth Your Attention and 2 to Turn Down
PODD

StockStory

5 months ago

1 Healthcare Stock Worth Your Attention and 2 to Turn Down

PODD

MT Newswires

5 months ago

Insulate Names Ashley McEvoy Chief Executive

Insulet Appoints Ashley McEvoy President and CEO
PODD

Business Wire

5 months ago

Insulet Appoints Ashley McEvoy President and CEO

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
PODD

Simply Wall St.

5 months ago

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger

PODD

Argus Research

5 months ago

PODD: Raising target price to $297.00

4 Medical Product Stocks to Buy From a Challenging Industry
PODD

Zacks

5 months ago

4 Medical Product Stocks to Buy From a Challenging Industry

PODD

Argus Research

5 months ago

PODD: Raising target price to $282.00

PODD

MT Newswires

5 months ago

RBC Cuts Price Target on Insulet to $325 From $340, Keeps Outperform Rating

Share on Social Networks: